bpc 157 peptide review BPC-157 for athletes and injury treatment: Science, safety, and legal concerns BPC-157: The Body Protection Compound

If a breastfeeding infant experiences an adverse effect related to a maternally ingested drug, healthcare providers are encouraged to report the adverse effect to the FDA

A 2018 paper in Current Pharmaceutical Design (Seiwerth S et al.) reviewed BPC-157's observed effects on angiogenesis the formation of new blood vessels and its potential role in tissue healing processes

Cyanocobalamin must first be converted to hydroxocobalamin, then to either methylcobalamin or adenosylcobalamin depending on tissue needs

Malinda KM, et al

For this reason, AOD 9604 should be treated as a research tool for metabolic pathway investigationnot an established treatment